Sánchez AR, Góngora AW, Goya BY, Miranda CA, Cobos VD, Cubeñas VG, Pérez MO

Language: Spanish
References: 16
Page: 101-107
PDF size: 130.64 Kb.

ABSTRACT

The risk of contamination with Toxoplasma gondii via blood transfusion is increased by the incidence of this parasite in donors and its tolerance to blood processing and storage processes, which turns it into a hazard for risk groups. This disease is not notifiable in Cuba. The interest in learning about the epidemiological behavior of this parasitosis led us to study 562 blood donor samples from the province of Guantánamo, 47.0 % of which tested positive for anti-T. gondii IgG, with over 62 % positivity in the municipalities of Baracoa and Maisí, and higher prevalence in rural areas. Neither the seropositivity values found in the age groups studied nor their sex distribution were significant, though contact with the parasite was higher in the 18-40 age group. These seroepidemiological data point to the need to propose control actions for the use of blood products in risk groups.

REFERENCES

1. Ajzenberg D, Bañuls AL, Su C, Dumètre A, Demar M, Carme B, Dardé ML. Intern J Parasitol. 2004;34:1185-96.

2. Cardo Figueroa R. El riesgo de transmisión de enfermedades infecciosas por vía de la transfusión. Ginecol Obstet Méx. 1998;66(7):277-83.

3. Suzuki Y, Wang X, Jortner BS, Payne L, Yanyan N, Michie SA, Baouhui X , Kudo T, Perkins S. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol. 2010;176(4):1607-13.

4. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Intern J Parasitol. 2009;39:877-82.

5. Raisanen S.T oxoplasmosis transmitted by blood transfusions. Transfusion. 1978;18:329-32.

6. Sundar P, Mahadevan A, Jayshree RS, Subbakrishna DK, Shankar SK. Toxoplasma seroprevalence in healthy voluntaryblood donors from urban Karnataka. Indian J Med Res. 2007;126:50-55.

7. Westphal R. Other parasitic organisms transmitted by transfusion En: Smith D, Dodd R, editors. Transfusion-transmitted infections. America Society of Clinical Pathologists. Chicago: U. Press; 1991. p. 181-93.

8. Cecil Med. Chapter 370. Toxoplasmosis, 23rd ed.; 2008. p. 2394-99.

9. Kitahata MM, Koepsell TD, Deyo RA. Physician's experience with adquired immunodeficiency syndrome as a factor in patient's survival. N Engl J Med. 1996;334:701-6.

10. Okome-Nkoumou M, Mbounja-Loclo ME, Kombila M. Spectrum of opportunistic infections in subjects infected with HIV. Santé. 2000;10:329-37.

11. Pinlaor S, Ieamviteevanich K, Pinlaor P, Maleewong W, Pipitgool V. Seroprevalence of specific total immunoglobulin (Ig), IgG and IgM antibodies to Toxoplasma gondii in blood donors from loci province, Northeast Thailand. Southeast Asian. J Trop Med Public Health. 2000;31:123-7.

12. Coelho RA, Kobayashi M, Carvalho LB, Jr. Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife, Northeast Brazil. Rev Inst Med Trop Sao Paulo. 2003;45:229-31.

13. Martín Hernández I, García Izquierdo SM. Prevalencia de anticuerpos IgG contra Toxoplasma gondii en donantes de sangre cubanos. Rev Bioméd. 2003;14(4):247-51.

14. Remington J, McLeod R, Desmonts G. Toxoplasmosis. En: Remington J, Klein, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders; 1995. p. 140-267.

15. Sánchez R, Goya Y, Góngora W, Cubeñas G, Cuevas B, Cobos D, et al. Pesquisa sobre seroprevalencia de Toxoplasma gondii en donantes de sangre en las provincias de Guantánamo y Santiago de Cuba. VacciMonitor. 2011:20(Suplemento 1):18.

16. Van Druten H, Van Knapen F, Reintjes A. Epidemiologic implication of limited duration seroposivity after toxoplasma infection. Am J Epidemiol. 1990;132:169-80.